Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Inflammatory eye disorders
•
Scleritis
•
Ophthalmology
•
General Infectious Disease
How do you approach treatment of tuberculous scleritis in pregnancy?
Related Questions
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
How often do you see bony erosions in patients with Lyme arthritis?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
What specific criteria or patient conditions would make you hesitant to use fluoroquinolones early in the treatment course for managing MSSA joint infections with oral antibiotics?
What is your approach to counseling patients regarding re-initiation of anti-TNF therapy after completion of treatment for non-disseminated pulmonary histoplasmosis?
What are your top takeaways from ID Week 2024?
How do you approach a patient who has anterior uveitis and is referred for evaluation of ocular TB with a positive Quantiferon gold (as part of their workup) in countries with low TB incidence?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
